Stay updated on Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and v3.5.0 was removed, indicating a minor software update.
    Difference
    0.0%
    Check dated 2026-04-16T11:12:17.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Difference
    0.0%
    Check dated 2026-04-09T08:37:30.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T20:21:01.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 with no visible changes to study content.
    Difference
    0.0%
    Check dated 2026-03-11T17:21:27.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the page. Deleted the funding/operating status notice and the older Revision: v3.4.1 reference from the page.
    Difference
    0.2%
    Check dated 2026-02-11T02:51:45.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The page now displays a government funding lapse notice and NIH operating status update, and the site revision has been updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.2%
    Check dated 2026-02-04T00:32:34.000Z thumbnail image

Stay in the know with updates to Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.